Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
J Nutr Biochem ; 114: 109272, 2023 04.
Article in English | MEDLINE | ID: mdl-36681309

ABSTRACT

This study was designed to evaluate the long-term effects of Fructose (20%) feeding in rats, simulating metabolic syndrome (MetS), and the effects of coconut oil (C.O.) supplementation when administered in a MetS context. MetS is a cluster of systemic conditions that represent an increased chance of developing cardiovascular diseases and type 2 diabetes in the future. C.O. has been the target of media speculation, and recent studies report inconsistent results. C.O. improved glucose homeostasis and reduced fat accumulation in Fructose-fed rats while decreasing the levels of triglycerides (TGs) in the liver. C.O. supplementation also increased TGs levels and fructosamine in serum during MetS, possibly due to white adipose tissue breakdown and high fructose feeding. Pro-inflammatory cytokines IL-1ß and TNF-α were also increased in rats treated with Fructose and C.O. Oxidative stress marker nitrotyrosine is increased in fructose-fed animals, and C.O. treatment did not prevent this damage. No significant changes were observed in lipoperoxidation marker 4-Hydroxynonenal; however, fructose feeding increased total conjugated dienes and caused conjugated dienes to switch their conformation from cis-trans to trans-trans, which was not prevented by C.O. treatment. Potential benefits of C.O. have been reported with inconsistent results, and indeed we observed some benefits of C.O. supplementation in aiding weight loss, fat accumulation, and improving glucose homeostasis. Nonetheless, we also demonstrated that long-term C.O. supplementation could present some problematic effects with higher risk for individuals suffering MetS, including increased TGs and fructosamine levels and conformational changes in dienes.


Subject(s)
Coconut Oil , Dietary Supplements , Metabolic Syndrome , Animals , Rats , Blood Glucose/metabolism , Coconut Oil/pharmacology , Coconut Oil/therapeutic use , Diabetes Mellitus, Type 2/etiology , Diabetes Mellitus, Type 2/metabolism , Fructosamine/metabolism , Fructosamine/pharmacology , Fructose/metabolism , Glucose/metabolism , Homeostasis , Liver/metabolism , Metabolic Syndrome/diet therapy , Metabolic Syndrome/metabolism , Oxidative Stress , Rats, Wistar , Inflammation/diet therapy , Inflammation/metabolism
2.
Nutr Neurosci ; 25(5): 1026-1040, 2022 May.
Article in English | MEDLINE | ID: mdl-33078695

ABSTRACT

Obesity is a health problem that has been associated with neuroinflammation, decreased cognitive functions and development of neurodegenerative diseases. Parkinson's disease (PD) is a chronic neurodegenerative condition characterized by motor and non-motor abnormalities, increased brain inflammation, α-synuclein protein aggregation and dopaminergic neuron loss that is associated with decreased levels of tyrosine hydroxylase (TH) in the brain. Diet-induced obesity is a global epidemic and its role as a risk factor for PD is not clear. Herein, we showed that 25 weeks on a high-fat diet (HFD) promotes significant alterations in the nigrostriatal axis of Wistar rats. Obesity induced by HFD exposure caused a reduction in TH levels and increased TH phosphorylation at serine 40 in the ventral tegmental area. These effects were associated with insulin resistance, increased tumor necrosis factor-α levels, oxidative stress, astrogliosis and microglia activation. No difference was detected in the levels of α-synuclein. Obesity also induced impairment of locomotor activity, total mobility and anxiety-related behaviors that were identified in the open-field and light/dark tasks. There were no changes in motor coordination or memory. Together, these data suggest that the reduction of TH levels in the nigrostriatal axis occurs through an α-synuclein-independent pathway and can be attributed to brain inflammation, oxidative/nitrosative stress and metabolic disorders induced by obesity.


Subject(s)
Encephalitis , Parkinson Disease , Animals , Brain/metabolism , Diet, High-Fat/adverse effects , Disease Models, Animal , Encephalitis/metabolism , Neuroinflammatory Diseases , Obesity/etiology , Obesity/metabolism , Oxidative Stress , Parkinson Disease/metabolism , Rats , Rats, Wistar , Tyrosine 3-Monooxygenase/metabolism , alpha-Synuclein/metabolism
3.
Phytother Res ; 33(5): 1394-1403, 2019 May.
Article in English | MEDLINE | ID: mdl-30868680

ABSTRACT

Obesity is a metabolic disorder associated with adverse health consequences that has increased worldwide at an epidemic rate. This has encouraged many people to utilize nonprescription herbal supplements for weight loss without knowledge of their safety or efficacy. However, mounting evidence has shown that some herbal supplements used for weight loss are associated with adverse effects. Guarana seed powder is a popular nonprescription dietary herb supplement marketed for weight loss, but no study has demonstrated its efficacy or safety when administered alone. Wistar rats were fed four different diets (low-fat diet and Western diet with or without guarana supplementation) for 18 weeks. Metabolic parameters, gut microbiota changes, and toxicity were then characterized. Guarana seed powder supplementation prevented weight gain, insulin resistance, and adipokine dysregulation induced by Western diet compared with the control diet. Guarana induced brown adipose tissue expansion, mitochondrial biogenesis, uncoupling protein-1 overexpression, AMPK activation, and minor changes in gut microbiota. Molecular docking suggested a direct activation of AMPK by four guarana compounds tested here. We propose that brown adipose tissue activation is one of the action mechanisms involved in guarana supplementation-induced weight loss and that direct AMPK activation may underlie this mechanism. In summary, guarana is an attractive potential therapeutic agent to treat obesity.


Subject(s)
Adipokines/metabolism , Adipose Tissue, Brown/drug effects , Insulin Resistance , Paullinia/chemistry , Animals , Diet, High-Fat/adverse effects , Diet, Western , Dietary Supplements , Humans , Male , Molecular Docking Simulation , Obesity/metabolism , Rats , Rats, Wistar , Weight Gain , Weight Loss/drug effects
4.
Neurochem Int ; 126: 27-35, 2019 06.
Article in English | MEDLINE | ID: mdl-30849398

ABSTRACT

Carvacrol (CARV) presents valuable biological properties such as anti-inflammatory and antioxidant activities. However, pharmacological uses of CARV are largely limited due to disadvantages related to solubility, bioavailability, preparation and storage processes. The complexation of monoterpenes with ß-cyclodextrin (ß-CD) increases their stability, solubility and oral bioavailability. Here, the protective effect of oral treatment with CARV/ß-CD complex (25 µg/kg/day) against dopaminergic (DA) denervation induced by unilateral intranigral injection of 6-hydroxydopamine (6-OHDA - 10 µg per rat) was analyzed, in order to evaluate a putative application in the development of neuroprotective therapies for Parkinson's disease (PD). Pretreatment with CARV/ß-CD for 15 days prevented the loss of DA neurons induced by 6-OHDA in adult Wistar rats. This effect may occur through CARV anti-inflammatory and antioxidant properties, as the pretreatment with CARV/ß-CD inhibited the release of IL-1ß and TNF-α; besides, CARV prevented the increase of mitochondrial superoxide production induced by 6-OHDA in cultured SH-SY5Y cells. Importantly, hepatotoxicity or alterations in blood cell profile were not observed with oral administration of CARV/ß-CD. Therefore, this study showed a potential pharmacological application of CARV/ß-CD in PD using a non-invasive route of drug delivery, i.e., oral administration.


Subject(s)
Cymenes/administration & dosage , Denervation/adverse effects , Dopaminergic Neurons/drug effects , Neuroprotective Agents/administration & dosage , Oxidopamine/toxicity , beta-Cyclodextrins/administration & dosage , Administration, Oral , Animals , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/pathology , Drug Combinations , Male , Oxidative Stress/drug effects , Oxidative Stress/physiology , Rats , Rats, Wistar
5.
Mol Neurobiol ; 56(5): 3079-3089, 2019 May.
Article in English | MEDLINE | ID: mdl-30094805

ABSTRACT

The receptor for advanced glycation endproducts (RAGE) is a transmembrane, immunoglobulin-like receptor that interacts with a broad repertoire of extracellular ligands. RAGE belongs to a family of cell adhesion molecules and is considered a key receptor in the inflammation axis and a potential contributor to the neurodegeneration. The present study aimed to investigate the content and cell localization of RAGE in the brain of Wistar rats subjected to systemic inflammation induced by a single dose of lipopolysaccharide (LPS, 5 mg/kg, i.p.). Fifteen days after LPS administration, the content of RAGE was analyzed in the prefrontal cortex (PFC), hippocampus (HIPP), cerebellum (CB), and substantia nigra (SN) were investigated. RAGE levels increased in all structures, except HIPP; however, immunohistochemistry analysis demonstrated that the cell site of RAGE expression changed from blood vessel-like structures to neuronal cells in all brain areas. Besides, the highest level of RAGE expression was found in SN. Immunofluorescence analysis in SN confirmed that RAGE expression was mainly co-localized in endothelial cells (RAGE/PECAM-1 co-staining) in untreated animals, while LPS-treated animals had RAGE expression predominantly in dopaminergic neurons (RAGE/TH co-staining). Decreased TH levels, as well as increased pro-inflammatory markers (TNF-α, IL-1ß, Iba-1, GFAP, and phosphorylated ERK1/2) in SN, occurred concomitantly to RAGE stimulation in the same site. These results suggest a role for RAGE in the establishment of a neuroinflammation-neurodegeneration axis that develops as a long-term response to systemic inflammation by LPS.


Subject(s)
Brain/metabolism , Brain/pathology , Endothelial Cells/metabolism , Inflammation/metabolism , Neurons/metabolism , Receptor for Advanced Glycation End Products/metabolism , Animals , Biomarkers/metabolism , Dopaminergic Neurons/metabolism , Inflammation/pathology , Lipopolysaccharides/pharmacology , Male , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Rats, Wistar , Substantia Nigra/metabolism , Tyrosine 3-Monooxygenase/metabolism
6.
Ecotoxicol Environ Saf ; 165: 44-51, 2018 Dec 15.
Article in English | MEDLINE | ID: mdl-30179764

ABSTRACT

Obesity is an important nutritional disorder worldwide. Its association with environmental pollution may trigger an increase in oxidative stress and inflammatory parameters. Coal is a resource used throughout the world as an important fuel source for generating electricity. The ashes released by the coal combustion cause serious problems for human health due to their high toxicity and their capacity to bioaccumulate. The aim of this work was to investigate the effects of coal dust inhalation in the organs of obese and non-obese Wistar rats. Pro-inflammatory cytokines, oxidative stress, oxidative damage, histological analysis, comet assay, and micronuclei were investigated. Both obesity and coal dust inhalation increased the pro-inflammatory cytokines IL-1ß and TNF-α and decreased HSP70 levels in serum, however, in obese animals that inhaled coal dust these changes were more pronounced. Liver histological analysis showed severe microvesicular steatosis in obese animals that inhaled coal dust. Lung histologic investigation showed abnormalities in lung structure of animals exposed to coal dust and showed severe lung distensibility in obese animals exposed to coal dust. The comet assay showed DNA damage in animals subjected to coal. In addition, there were modulations in enzymatic activities and damage to protein and lipids. Based on our results, the coal dust inhalation can potentiate the pro-inflammatory profile present in obese rats. We also observed an increase in the protein oxidative damage in obese rats that inhaled coal dust. Taken together, our results suggest that the combination of obesity and coal inhalation increased the risks of the development of diseases related to oxidative stress and inflammation.


Subject(s)
Coal/toxicity , DNA Damage , Obesity/pathology , Oxidative Stress , Administration, Inhalation , Animals , Cytokines/blood , Dust , Inflammation Mediators/blood , Liver/drug effects , Liver/pathology , Lung/drug effects , Lung/pathology , Male , Obesity/blood , Obesity/metabolism , Rats , Rats, Wistar
7.
Biomedicines ; 5(3)2017 Aug 29.
Article in English | MEDLINE | ID: mdl-29093434

ABSTRACT

Achyrocline satureioides (AS, family Asteraceae) is a plant widely used in traditional medicine for stomach, digestive, and gastrointestinal disorders during pregnancy. Studies regarding the indiscriminate use of plant infusions during pregnancy are limited. Recent reports have shown that chronic flavonoid supplementation induces toxicity in vivo and raises the mortality rates of healthy subjects. Therefore, we investigated whether supplementation of pregnant and lactating Wistar rats with two AS inflorescence extracts, consisting of an aqueous (AQ) extract similar to a tea (47 mg·kg-1·day) and a hydroethanolic (HA) extract (35 mg·kg-1·day-1) with a higher flavonoid content, could induce redox-related side effects. Total reactive antioxidant potential (TRAP), thiobarbituric reactive species (TBARS), and total reduced thiol (SH) content were evaluated. Superoxide dismutase (SOD) and catalase (CAT) activities were additionally quantified. Our data suggest that both AQ and HA of AS inflorescence extracts may induce symptoms of toxicity in concentrations of (47 mg·kg-1·day) and (35 mg·kg-1·day-1), respectively, in mothers regarding the delivery index and further decrease of neonatal survival. Of note, significant tissue-specific changes in maternal (liver, kidney, heart, and hippocampus) and pups (liver and kidney) biochemical oxidative parameters were observed. Our findings provide evidence that may support the need to control supplementation with the AQ of AS inflorescence extracts during gestation due to potential toxicity in vivo, which might be related, at least in part, to changes in tissue-specific redox homeostasis and enzymatic activity.

8.
Sci Rep ; 7(1): 8795, 2017 08 18.
Article in English | MEDLINE | ID: mdl-28821831

ABSTRACT

The receptor for advanced glycation endproducts (RAGE) is a pattern-recognition receptor associated with inflammation in most cell types. RAGE up-regulates the expression of proinflammatory mediators and its own expression via activation of NF-kB. Recent works have proposed a role for RAGE in Parkinson's disease (PD). In this study, we used the multimodal blocker of RAGE FPS-ZM1, which has become available recently, to selectively inhibit RAGE in the substantia nigra (SN) of rats intracranially injected with 6-hydroxydopamine (6-OHDA). FPS-ZM1 (40 µg per rat), injected concomitantly with 6-OHDA (10 µg per rat) into the SN, inhibited the increase in RAGE, activation of ERK1/2, Src and nuclear translocation of NF-kB p65 subunit in the SN. RAGE inhibition blocked glial fibrillary acidic protein and Iba-1 upregulation as well as associated astrocyte and microglia activation. Circulating cytokines in serum and CSF were also decreased by FPS-ZM1 injection. The loss of tyrosine hydroxylase and NeuN-positive neurons was significantly inhibited by RAGE blocking. Finally, FPS-ZM1 attenuated locomotory and exploratory deficits induced by 6-OHDA. Our results demonstrate that RAGE is an essential component in the neuroinflammation and dopaminergic denervation induced by 6-OHDA in the SN. Selective inhibition of RAGE may offer perspectives for therapeutic approaches.


Subject(s)
Dopamine/metabolism , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Oxidopamine/adverse effects , Receptor for Advanced Glycation End Products/antagonists & inhibitors , Substantia Nigra/metabolism , Animals , Cytokines/metabolism , Disease Models, Animal , Dopaminergic Neurons/pathology , Inflammation Mediators/metabolism , Male , NF-kappa B/metabolism , Parkinson Disease/etiology , Parkinson Disease/metabolism , Parkinson Disease/pathology , Rats , Substantia Nigra/drug effects , Substantia Nigra/pathology , src-Family Kinases/metabolism
9.
Appl Physiol Nutr Metab ; 42(11): 1192-1200, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28742973

ABSTRACT

The use of dietary supplements to enhance the benefit of exercise training is a common practice. The liver is the organ where all substances are metabolized, and certain supplements have been associated with liver injury. Vitamin A (VA), a liposoluble vitamin stored in the liver, is commonly used as an antioxidant supplement. Here, we evaluated the effect of chronic VA supplementation on oxidative damage and stress parameters in trained rats. Animals were divided into the following groups: sedentary (SE), sedentary/VA (SE+VA), exercise training (ET), and exercise training/VA (ET+VA). During 8 weeks, animals were subjected to swimming (0%, 2%, 4%, 6% body weight) for 5 days/week and a VA daily intake of 450 retinol equivalents/day. Parameters were evaluated by enzymatic activity analysis, ELISA, and Western blotting. VA caused liver lipid peroxidation and protein damage in exercised rats and inhibited the increase in HSP70 expression acquired with exercise alone. The ET group showed higher levels of antioxidant enzyme activity, and VA inhibited this adaptation. Expression of the pro-inflammatory cytokines, interleukin (IL)-1ß, and tumor necrosis factor-α was reduced in the ET+VA group, while the anti-inflammatory cytokine, IL-10, was increased. Western blotting showed that both exercised groups had lower levels of the receptor for advanced glycation end products, suggesting that VA did not affect this receptor. Our study demonstrated that, although VA caused oxidative damage, a controlled administration might exert anti-inflammatory effects. Further studies with higher VA doses and longer ET interventions would elucidate more the effects of the supplementation and exercise on liver parameters.


Subject(s)
Dietary Supplements , Liver/drug effects , Oxidative Stress/drug effects , Physical Conditioning, Animal , Vitamin A/administration & dosage , Administration, Oral , Alanine Transaminase/blood , Animals , Antioxidants , Aspartate Aminotransferases/blood , Cytokines/blood , Disease Models, Animal , Dose-Response Relationship, Drug , Lipid Peroxidation/drug effects , Liver/metabolism , Male , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Superoxide Dismutase/blood , Swimming , Thiobarbituric Acid Reactive Substances/metabolism
10.
Nutrients ; 9(4)2017 Apr 02.
Article in English | MEDLINE | ID: mdl-28368329

ABSTRACT

Exercise training intensity is the major variant that influences the relationship between exercise, redox balance, and immune response. Supplement intake is a common practice for oxidative stress prevention; the effects of vitamin A (VA) on exercise training are not yet described, even though this molecule exhibits antioxidant properties. We investigated the role of VA supplementation on redox and immune responses of adult Wistar rats subjected to swimming training. Animals were divided into four groups: sedentary, sedentary + VA, exercise training, and exercise training + VA. Over eight weeks, animals were submitted to intense swimming 5 times/week and a VA daily intake of 450 retinol equivalents/day. VA impaired the total serum antioxidant capacity acquired by exercise, with no change in interleukin-1ß and tumor necrosis factor-α levels. In skeletal muscle, VA caused lipid peroxidation and protein damage without differences in antioxidant enzyme activities; however, Western blot analysis showed that expression of superoxide dismutase-1 was downregulated, and upregulation of superoxide dismutase-2 induced by exercise was blunted by VA. Furthermore, VA supplementation decreased anti-inflammatory interleukin-10 and heat shock protein 70 expression, important factors for positive exercise adaptations and tissue damage prevention. Our data showed that VA supplementation did not confer any antioxidative and/or protective effects, attenuating exercise-acquired benefits in the skeletal muscle.


Subject(s)
Dietary Supplements/adverse effects , HSP70 Heat-Shock Proteins/antagonists & inhibitors , Interleukin-10/antagonists & inhibitors , Muscle, Skeletal/metabolism , Myositis/etiology , Oxidative Stress , Vitamin A/adverse effects , Animals , Biomarkers/blood , Biomarkers/metabolism , Blotting, Western , HSP70 Heat-Shock Proteins/metabolism , Inflammation Mediators/blood , Inflammation Mediators/metabolism , Interleukin-10/metabolism , Lipid Peroxidation , Male , Muscle, Skeletal/enzymology , Muscle, Skeletal/immunology , Myositis/blood , Myositis/immunology , Myositis/metabolism , Oxidoreductases/antagonists & inhibitors , Oxidoreductases/chemistry , Oxidoreductases/metabolism , Oxygen Radical Absorbance Capacity , Physical Conditioning, Animal/adverse effects , Random Allocation , Rats, Wistar
11.
Mem Inst Oswaldo Cruz ; 112(2): 146-154, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28177049

ABSTRACT

BACKGROUND: Leishmaniasis is a parasitosis caused by several species of the genus Leishmania. These parasites present high resistance against oxidative stress generated by inflammatory cells. OBJECTIVES: To investigate oxidative stress and molecular inflammatory markers in BALB/c mice infected with L. amazonensis and the effect of antioxidant treatment on these parameters. METHODS: Four months after infection, oxidative and inflammatory parameters of liver, kidneys, spleen, heart and lungs from BALB/c mice were assessed. FINDINGS: In liver, L. amazonensis caused thiol oxidation and nitrotyrosine formation; SOD activity and SOD2 protein content were increased while SOD1 protein content decreased. The content of the cytokines IL-1ß, IL-6, TNF-α, and the receptor of advanced glycation endproducts (RAGE) increased in liver. Treatment with the antioxidant N-acetyl-cysteine (20 mg/kg b.w) for five days inhibited oxidative stress parameters. MAIN CONCLUSIONS: L. amazonensis induces significant alterations in the redox status of liver but not in other organs. Acute antioxidant treatment alleviates oxidative stress in liver, but it had no effect on pro-inflammatory markers. These results indicate that the pathobiology of leishmaniasis is not restricted to the cutaneous manifestations and open perspectives for the development of new therapeutic approaches to the disease, especially for liver function.


Subject(s)
Acetylcysteine/pharmacology , Free Radical Scavengers/pharmacology , Leishmania mexicana , Leishmaniasis, Cutaneous/metabolism , Liver/drug effects , Oxidative Stress/drug effects , Animals , Leishmaniasis, Cutaneous/pathology , Liver/enzymology , Mice , Mice, Inbred BALB C , Oxidative Stress/physiology
12.
Mem. Inst. Oswaldo Cruz ; 112(2): 146-154, Feb. 2017. graf
Article in English | LILACS | ID: biblio-841766

ABSTRACT

BACKGROUND Leishmaniasis is a parasitosis caused by several species of the genus Leishmania. These parasites present high resistance against oxidative stress generated by inflammatory cells. OBJECTIVES To investigate oxidative stress and molecular inflammatory markers in BALB/c mice infected with L. amazonensis and the effect of antioxidant treatment on these parameters. METHODS Four months after infection, oxidative and inflammatory parameters of liver, kidneys, spleen, heart and lungs from BALB/c mice were assessed. FINDINGS In liver, L. amazonensis caused thiol oxidation and nitrotyrosine formation; SOD activity and SOD2 protein content were increased while SOD1 protein content decreased. The content of the cytokines IL-1β, IL-6, TNF-α, and the receptor of advanced glycation endproducts (RAGE) increased in liver. Treatment with the antioxidant N-acetyl-cysteine (20 mg/kg b.w) for five days inhibited oxidative stress parameters. MAIN CONCLUSIONS L. amazonensis induces significant alterations in the redox status of liver but not in other organs. Acute antioxidant treatment alleviates oxidative stress in liver, but it had no effect on pro-inflammatory markers. These results indicate that the pathobiology of leishmaniasis is not restricted to the cutaneous manifestations and open perspectives for the development of new therapeutic approaches to the disease, especially for liver function.


Subject(s)
Animals , Mice , Acetylcysteine/pharmacology , Leishmania mexicana , Leishmaniasis, Cutaneous/metabolism , Leishmaniasis, Cutaneous/pathology , Oxidative Stress/drug effects , Oxidative Stress/physiology , Free Radical Scavengers/pharmacology , Liver/drug effects , Liver/enzymology , Mice, Inbred BALB C
13.
Brain Behav Immun ; 62: 124-136, 2017 May.
Article in English | MEDLINE | ID: mdl-28088642

ABSTRACT

Systemic inflammation induces transient or permanent dysfunction in the brain by exposing it to soluble inflammatory mediators. The receptor for advanced glycation endproducts (RAGE) binds to distinct ligands mediating and increasing inflammatory processes. In this study we used an LPS-induced systemic inflammation model in rats to investigate the effect of blocking RAGE in serum, liver, cerebrospinal fluid (CSF) and brain (striatum, prefrontal cortex, ventral tegmental area and substantia nigra). Intraperitoneal injection of RAGE antibody (50µg/kg) was followed after 1h by a single LPS (5mg/kg) intraperitoneal injection. Twenty-four hours later, tissues were isolated for analysis. RAGE antibody reduced LPS-induced inflammatory effects in both serum and liver; the levels of proinflammatory cytokines (TNF-α, IL-1ß) were decreased and the phosphorylation/activation of RAGE downstream targets (ERK1/2, IκB and p65) in liver were significantly attenuated. RAGE antibody prevented LPS-induced effects on TNF-α and IL-1ß in CSF. In striatum, RAGE antibody inhibited increases in IL-1ß, Iba-1, GFAP, phospho-ERK1/2 and phospho-tau (ser202), as well as the decrease in synaptophysin levels. These effects were caused by systemic RAGE inhibition, as RAGE antibody did not cross the blood-brain barrier. RAGE antibody also prevented striatal lipoperoxidation and activation of mitochondrial complex II. In conclusion, blockade of RAGE is able to inhibit inflammatory responses induced by LPS in serum, liver, CSF and brain.


Subject(s)
Antibodies/pharmacology , Corpus Striatum/drug effects , Inflammation/drug therapy , Lipopolysaccharides/pharmacology , Liver/drug effects , Receptor for Advanced Glycation End Products/immunology , Animals , Antibodies/therapeutic use , Corpus Striatum/metabolism , Cytokines/metabolism , Inflammation/chemically induced , Inflammation/metabolism , Inflammation Mediators/metabolism , Interleukin-1beta/metabolism , Liver/metabolism , Male , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/metabolism
14.
Biopreserv Biobank ; 15(3): 182-190, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27662116

ABSTRACT

Most scientific studies are too long to be conducted in a single day or even in a few days. Thus, there is a need to store samples for subsequent investigations. There is sparse information about specific sample storage protocols that minimize analytical error and variability in evaluations of redox parameters. Therefore, the effects of storage temperature and freezing time on enzymatic activities, protein oxidative damage, and CAT (catalase) and SOD1 (superoxide dismutase) immunocontent of blood, liver, and brain from rats were determined for two different sample forms (frozen homogenized tissue or frozen intact tissue). Superoxide dismutase activity was drastically decreased in blood and liver with an increase in freezing time, but not in brain. Catalase activity showed a decrease only in intact liver at -20 and -80°C. In contrast, in blood it showed an increase in intact tissue at -20 and -80°C. Reduced thiol groups generally decreased with freezing time, but showed an increase in intact blood at -20 and -80°C, probably because of color interference. Carbonyl groups in homogenized liver and brain, and in intact blood (except at 80°C) drastically increased with freezing time. Freezing time did not modulate the immunocontent of CAT and SOD1 levels in any tissue. In conclusion, our results indicate that storage at -20°C affects redox parameters more than storage at -80°C. Storage for a long time may compromise the samples, leading to changing parameters due to oxidative stress. Thus, we suggest processing the samples as soon as possible. However, if this is not possible, then material can be aliquoted into different tubes to prevent the effect of refreezing of samples.


Subject(s)
Brain/enzymology , Freezing , Liver/enzymology , Specimen Handling/standards , Animals , Brain/immunology , Catalase/blood , Catalase/immunology , Catalase/metabolism , Heating , Liver/immunology , Oxidation-Reduction , Rats , Superoxide Dismutase/blood , Superoxide Dismutase/immunology , Superoxide Dismutase/metabolism
15.
Mol Neurobiol ; 54(9): 6903-6916, 2017 11.
Article in English | MEDLINE | ID: mdl-27771902

ABSTRACT

Human neuroblastoma SH-SY5Y cells have been used as an in vitro model for neurodegenerative disorders such as Parkinson's disease and can be induced to a mature neuronal phenotype through retinoic acid (RA) differentiation. However, mechanisms of RA-induced differentiation remain unclear. Here, we investigate the role of reactive species (RS) on SH-SY5Y neuroblastoma cells under RA differentiation, using the antioxidant Trolox® as co-treatment. We found that RA treatment for 7 days reduced the cell number and proliferative capacity and induced the expression of adult catecholaminergic/neuronal markers such as tyrosine hydroxylase (TH), ß-III tubulin, and enolase-2. Evaluation of intracellular RS production by DCFH oxidation assay and quantification of cell non-enzymatic antioxidant activity by TRAP demonstrated that RA increases RS production. Furthermore, mitochondrial NADH oxidation showed to be inhibited under differentiation with RA. Cells subjected to co-treatment with antioxidant Trolox® demonstrated a remaining proliferative capacity and a decrease in the pro-oxidant state and RS production. Besides, antioxidant treatment restores the mitochondrial NADH oxidation. Importantly, Trolox® co-treatment inhibited the appearance of morphological characteristics such as neurite extension and branching, and decreased the expression of TH, ß-III tubulin, and enolase-2 after a seven-day differentiation with RA, indicating that RS production is a necessary step in this process. Trolox® also inhibited the phosphorylation of Akt and ERK1/2, which are involved in differentiation and survival, respectively, of these cells. Altogether, these data indicate the presence of a redox-dependent mechanism in SH-SY5Y RA-differentiation process and can be a useful insight to improve understanding of neuronal differentiation signaling.


Subject(s)
Biomarkers/metabolism , Cell Cycle/drug effects , Cell Differentiation/drug effects , Neurons/cytology , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Tretinoin/pharmacology , Up-Regulation/drug effects , Antioxidants/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Shape/drug effects , Cell Survival/drug effects , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Mitochondria/drug effects , Mitochondria/metabolism , Neurons/drug effects , Neurons/metabolism , Phenotype , Phosphorylation/drug effects , Proto-Oncogene Proteins c-akt/metabolism
16.
J Nutr Biochem ; 32: 181-8, 2016 06.
Article in English | MEDLINE | ID: mdl-27142750

ABSTRACT

Menopause occurs gradually and is characterized by increased susceptibility to developing mood disorders. Several studies have suggested treatments based on the antioxidant properties of vitamins and herbal compounds as an alternative to hormone replacement therapies, with few or none reporting toxicity. The present study was performed to explore the effects of curcumin oral supplementation on anxiety-like behavior and oxidative stress parameters in different central nervous system (CNS) areas of ovariectomized (OVX) rats. Female Wistar rats were randomly divided into either sham-operated or OVX groups. Sham-operated group (n=8) and an OVX group (n=11) were treated with vehicle, and the other two OVX groups received curcumin at 50 or 100mg/kg/day doses (n=8/group). Elevated plus maze (EPM) test was performed on the 28th day of treatment. On the 30th day, animals were killed and the dissected brain regions were removed and stored at-80°C until analysis. Ovariectomy induced deficit in the locomotor activity and increased anxiety-like behavior. Moreover, OVX rats showed increased lipid oxidized in the frontal cortex and striatum, increased hippocampal and striatal carbonylated protein level, and decreased striatal thiol content of non-protein fraction indicative of a glutathione (GSH) pool. Curcumin oral treatment for 30days reduced oxidative stress in the CNS areas as well as the behavior alterations resulting from ovariectomy. Curcumin supplementation attenuated most of these parameters to sham comparable values, suggesting that curcumin could have positive effects against anxiety-like disturbances and brain oxidative damage due to hormone deprivation.


Subject(s)
Antioxidants/therapeutic use , Cognitive Dysfunction/prevention & control , Curcumin/therapeutic use , Dietary Supplements , Neurons/metabolism , Oxidative Stress , Postmenopause , Animals , Antioxidants/administration & dosage , Anxiety/metabolism , Anxiety/prevention & control , Behavior, Animal , Biomarkers/metabolism , Cognitive Dysfunction/metabolism , Corpus Striatum/growth & development , Corpus Striatum/metabolism , Curcumin/administration & dosage , Female , Frontal Lobe/growth & development , Frontal Lobe/metabolism , Hippocampus/growth & development , Hippocampus/metabolism , Maze Learning , Mood Disorders/metabolism , Mood Disorders/prevention & control , Ovariectomy , Protein Carbonylation , Psychomotor Disorders/metabolism , Psychomotor Disorders/prevention & control , Random Allocation , Rats, Wistar
17.
Ecotoxicol Environ Saf ; 129: 16-24, 2016 Jul.
Article in English | MEDLINE | ID: mdl-26970882

ABSTRACT

Tropospheric ozone (O3) background concentrations have increased since pre-industrial times, reaching phytotoxic concentrations in many regions globally. However, the effect of high O3 concentrations on quality of fruit and vegetables remains unknown. Here, we evaluated whether O3 pollution alters the quality of Capsicum baccatum peppers by changing the secondary compound profiles and biological activity of the fruit. C. baccatum pepper plants were exposed to ozone for 62 days in an open-top chamber at a mean O3 concentration of 171.6µg/m(3). Capsaicin levels decreased by 50% in the pericarp, but remained unchanged in the seeds. In contrast, the total carotenoid content increased by 52.8% in the pericarp. The content of total phenolic compounds increased by 17% in the pericarp. The total antioxidant potential decreased by 87% in seeds of O3-treated plants. The seeds contributed more than the pericarp to the total radical-trapping antioxidant potential and total antioxidant reactivity. O3 treatment impaired the ferric-reducing antioxidant power of the seeds and reduced NO(•)-scavenging activity in the pericarp. However, O3 treatment increased ferrous ion-chelating activity and hydroxyl radical-scavenging activity in the pericarp. Our results confirm that O3 alters the secondary metabolite profile of C. baccatum pepper fruits and, consequently, their biological activity profile.


Subject(s)
Air Pollutants/toxicity , Capsicum/drug effects , Oxidants/toxicity , Ozone/toxicity , Anti-Inflammatory Agents/metabolism , Antioxidants/metabolism , Capsaicin/metabolism , Capsicum/metabolism , Carotenoids/metabolism , Fruit/drug effects , Fruit/metabolism , Phenols/metabolism , Seeds/drug effects , Seeds/metabolism
18.
Oxid Med Cell Longev ; 2016: 5719291, 2016.
Article in English | MEDLINE | ID: mdl-26640615

ABSTRACT

The aim of this study was to investigate the potential of curcumin oral supplementation (50 and 100 mg/Kg/day, for 30 days) in circumventing menopause-associated oxidative stress and lipid profile dysfunctions in a rat ovariectomy (OVX) model. Female Wistar rats were operated and randomly divided into either sham-operated or OVX groups. Sham-operated group (n = 8) and one OVX group (n = 11) were treated with vehicle (refined olive oil), and the other two OVX groups received curcumin at 50 or 100 mg/Kg/day doses (n = 8/group). OVX vehicle-treated animals presented a higher deposition of intestinal adipose tissue as well as increased serum levels of IL-6, LDL, and total cholesterol when compared to sham-operated rats. In addition, several oxidative stress markers in serum, blood, and liver (such as TBARS, carbonyl, reduced-sulphydryl, and nonenzymatic antioxidant defenses) were altered toward a prooxidant status by OVX. Interestingly, curcumin supplementation attenuated most of these parameters to sham comparable values. Thus, the herein presented results show that curcumin may be useful to ameliorate lipid metabolism alterations and oxidative damage associated with hormone deprivation in menopause.


Subject(s)
Adiposity/drug effects , Cholesterol, LDL/blood , Curcumin/pharmacology , Menopause/blood , Ovariectomy , Oxidative Stress/drug effects , Animals , Female , Interleukin-6/blood , Rats , Rats, Wistar
19.
Appl Physiol Nutr Metab ; 40(12): 1253-61, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26566243

ABSTRACT

Exercise training induces reactive oxygen species production and low levels of oxidative damage, which are required for induction of antioxidant defenses and tissue adaptation. This process is physiological and essential to improve physical conditioning and performance. During exercise, endogenous antioxidants are recruited to prevent excessive oxidative stress, demanding appropriate intake of antioxidants from diet or supplements; in this context, the search for vitamin supplements that enhance the antioxidant defenses and improve exercise performance has been continuously increasing. On the other hand, excess of antioxidants may hinder the pro-oxidant signals necessary for this process of adaptation. The aim of this study was to investigate the effects of vitamin A supplementation (2000 IU/kg, oral) upon oxidative stress and parameters of pro-inflammatory signaling in lungs of rats submitted to aerobic exercise (swimming protocol). When combined with exercise, vitamin A inhibited biochemical parameters of adaptation/conditioning by attenuating exercise-induced antioxidant enzymes (superoxide dismutase and glutathione peroxidase) and decreasing the content of the receptor for advanced glycation end-products. Increased oxidative damage to proteins (carbonylation) and lipids (lipoperoxidation) was also observed in these animals. In sedentary animals, vitamin A decreased superoxide dismutase and increased lipoperoxidation. Vitamin A also enhanced the levels of tumor necrosis factor alpha and decreased interleukin-10, effects partially reversed by aerobic training. Taken together, the results presented herein point to negative effects associated with vitamin A supplementation at the specific dose here used upon oxidative stress and pro-inflammatory cytokines in lung tissues of rats submitted to aerobic exercise.


Subject(s)
Dietary Supplements/toxicity , Lung/drug effects , Oxidants/toxicity , Oxidative Stress/drug effects , Physical Exertion , Vitamin A/toxicity , Animals , Glutathione Peroxidase/metabolism , Inflammation Mediators/metabolism , Interleukin-10/metabolism , Lipid Peroxidation/drug effects , Lung/metabolism , Male , Protein Carbonylation/drug effects , Rats, Wistar , Reactive Oxygen Species/metabolism , Receptor for Advanced Glycation End Products/metabolism , Superoxide Dismutase/metabolism , Swimming , Time Factors , Tumor Necrosis Factor-alpha/metabolism
20.
Brain Behav Immun ; 43: 37-45, 2015 01.
Article in English | MEDLINE | ID: mdl-25014011

ABSTRACT

Leishmaniasis is a parasitosis caused by several species of the genus Leishmania, an obligate intramacrophagic parasite. Although neurologic symptoms have been observed in human cases of leishmaniasis, the manifestation of neurodegenerative processes is poorly studied. The aim of the present work was to investigate if peripheral infection of BALB/c mice with Leishmania amazonensis affects tau phosphorylation and RAGE protein content in the brain, which represent biochemical markers of neurodegenerative processes observed in diseases with a pro-inflammatory component, including Alzheimer's disease and Down syndrome. Four months after a single right hind footpad subcutaneous injection of L. amazonensis, the brain cortex of BALB/c mice was isolated. Western blot analysis indicated an increase in tau phosphorylation (Ser(396)) and RAGE immunocontent in infected animals. Brain tissue TNF-α, IL-1ß, and IL-6 levels were not different from control animals; however, increased protein carbonylation, decreased IFN-γ levels and impairment in antioxidant defenses were detected. Systemic antioxidant treatment (NAC 20mg/kg, i.p.) inhibited tau phosphorylation and recovered IFN-γ levels. These data, altogether, indicate an association between impaired redox state, tau phosphorylation and RAGE up-regulation in the brain cortex of animals infected with L. amazonensis. In this context, it is possible that neurologic symptoms associated to chronic leishmaniasis are associated to disruptions in the homeostasis of CNS proteins, such as tau and RAGE, as consequence of oxidative stress. This is the first demonstration of alterations in biochemical parameters of neurodegeneration in an experimental model of Leishmania infection.


Subject(s)
Brain/parasitology , Leishmania mexicana , Leishmaniasis/metabolism , Receptors, Immunologic/metabolism , tau Proteins/metabolism , Animals , Brain/metabolism , Cytokines/metabolism , Mice , Mice, Inbred BALB C , Oxidative Stress/physiology , Phosphorylation , Receptor for Advanced Glycation End Products , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...